Koers GINO BIOW Nasdaq
Aandelen
DNA
US37611X1000
Biotechnologie & Medisch Onderzoek
Omzet 2024 * | 223 mln. 210 mln. | Omzet 2025 * | 310 mln. 291 mln. | Marktkapitalisatie | 1,85 mld. 1,74 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -631 mln. -592 mln. | Nettowinst (verlies) 2025 * | -534 mln. -501 mln. | EV/omzet 2024 * | 5,26 x |
Nettoliquiditeiten 2024 * | 676 mln. 635 mln. | Nettoliquiditeiten 2025 * | 550 mln. 516 mln. | EV/omzet 2025 * | 4,2 x |
K/w-verhouding 2024 * |
-2,89
x | K/w-verhouding 2025 * |
-3,4
x | Werknemers | 1.218 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 66,98% |
Recentste transcriptie over GINO BIOW
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Austin Che
FOU | Founder | - | 01-01-08 |
Founder | - | 01-01-08 | |
Reshma Shetty
FOU | Founder | 43 | 01-01-08 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Christian Henry
BRD | Director/Board Member | 56 | 16-09-21 |
Marijn Dekkers
CHM | Chairman | 65 | 16-09-21 |
Kathy Hannan
BRD | Director/Board Member | 62 | 02-08-22 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,42% | 41,35 mld. | |
+42,15% | 40,38 mld. | |
+1,97% | 39,05 mld. | |
-14,19% | 26,67 mld. | |
+1,82% | 24,07 mld. | |
-24,55% | 18,36 mld. | |
-4,07% | 11,68 mld. | |
+21,36% | 11,6 mld. | |
+8,20% | 11,15 mld. |